Year |
Citation |
Score |
2020 |
Steinebach C, Ng YLD, Sosič I, Lee CS, Chen S, Lindner S, Vu LP, Bricelj A, Haschemi R, Monschke M, Steinwarz E, Wagner KG, Bendas G, Luo J, Gütschow M, et al. Systematic exploration of different E3 ubiquitin ligases: an approach towards potent and selective CDK6 degraders. Chemical Science. 11: 3474-3486. PMID 33133483 DOI: 10.1039/d0sc00167h |
0.509 |
|
2019 |
Lee CS, Lee LC, Yuan TL, Chakka S, Fellmann C, Lowe SW, Caplen NJ, McCormick F, Luo J. MAP kinase and autophagy pathways cooperate to maintain RAS mutant cancer cell survival. Proceedings of the National Academy of Sciences of the United States of America. PMID 30709910 DOI: 10.1073/Pnas.1817494116 |
0.399 |
|
2018 |
Yuan TL, Amzallag A, Bagni R, Yi M, Afghani S, Burgan W, Fer N, Strathern LA, Powell K, Smith B, Waters AM, Drubin D, Thomson T, Liao R, Greninger P, ... ... Lee CS, et al. Differential Effector Engagement by Oncogenic KRAS. Cell Reports. 22: 1889-1902. PMID 29444439 DOI: 10.1016/J.Celrep.2018.01.051 |
0.423 |
|
2015 |
Yu B, Swatkoski S, Holly A, Lee LC, Giroux V, Lee CS, Hsu D, Smith JL, Yuen G, Yue J, Ann DK, Simpson RM, Creighton CJ, Figg WD, Gucek M, et al. Oncogenesis driven by the Ras/Raf pathway requires the SUMO E2 ligase Ubc9. Proceedings of the National Academy of Sciences of the United States of America. 112: E1724-33. PMID 25805818 DOI: 10.1073/Pnas.1415569112 |
0.305 |
|
2014 |
Yu B, Swatkoski S, Holly A, Lee LC, Giroux V, Lee C, Carver J, Creighton C, Ann DK, Figg WD, Gucek M, Luo J. Abstract B29: A critical role of the SUMO pathway in KRAS-driven oncogenesis Molecular Cancer Research. 12. DOI: 10.1158/1557-3125.Rasonc14-B29 |
0.386 |
|
2011 |
Lee CS, Dykema KJ, Hawkins DM, Cherba DM, Webb CP, Furge KA, Duesbery NS. MEK2 is sufficient but not necessary for proliferation and anchorage-independent growth of SK-MEL-28 melanoma cells. Plos One. 6: e17165. PMID 21365009 DOI: 10.1371/Journal.Pone.0017165 |
0.422 |
|
2010 |
Bromberg-White J, Lee CS, Duesbery N. Consequences and utility of the zinc-dependent metalloprotease activity of anthrax lethal toxin. Toxins. 2: 1038-53. PMID 22069624 DOI: 10.3390/Toxins2051038 |
0.41 |
|
2010 |
Lee C, Dykema KJ, Hawkins DM, Furge KA, Duesbery NS. Abstract LB-232: MEK2 signaling pathway alone is sufficient but not necessary for melanoma cell proliferation Cancer Research. 70. DOI: 10.1158/1538-7445.Am10-Lb-232 |
0.505 |
|
Show low-probability matches. |